- Home
- FRME vs CNTA Comparison
FRME vs CNTA Comparison
Compare FRME & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRME
- CNTA
- Stock Information
- Founded
- FRME 1893
- CNTA 2020
- Country
- FRME United States
- CNTA United Kingdom
- Employees
- FRME N/A
- CNTA N/A
- Industry
- FRME Major Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- FRME Finance
- CNTA Health Care
- Exchange
- FRME Nasdaq
- CNTA Nasdaq
- Market Cap
- FRME 2.1B
- CNTA 1.6B
- IPO Year
- FRME N/A
- CNTA 2021
- Fundamental
- Price
- FRME $40.33
- CNTA $13.74
- Analyst Decision
- FRME Buy
- CNTA Strong Buy
- Analyst Count
- FRME 4
- CNTA 10
- Target Price
- FRME $44.75
- CNTA $28.78
- AVG Volume (30 Days)
- FRME 362.6K
- CNTA 1.2M
- Earning Date
- FRME 07-23-2025
- CNTA 08-12-2025
- Dividend Yield
- FRME 3.62%
- CNTA N/A
- EPS Growth
- FRME 2.61
- CNTA N/A
- EPS
- FRME 3.55
- CNTA N/A
- Revenue
- FRME $615,411,000.00
- CNTA $15,000,000.00
- Revenue This Year
- FRME $15.14
- CNTA N/A
- Revenue Next Year
- FRME $5.03
- CNTA N/A
- P/E Ratio
- FRME $11.20
- CNTA N/A
- Revenue Growth
- FRME N/A
- CNTA 118.88
- 52 Week Low
- FRME $32.28
- CNTA $8.46
- 52 Week High
- FRME $46.13
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- FRME 68.46
- CNTA 58.98
- Support Level
- FRME $37.65
- CNTA $12.74
- Resistance Level
- FRME $37.82
- CNTA $14.27
- Average True Range (ATR)
- FRME 1.13
- CNTA 0.69
- MACD
- FRME 0.43
- CNTA 0.10
- Stochastic Oscillator
- FRME 96.85
- CNTA 78.96
About FRME First Merchants Corporation
First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.